View Item 

Show simple item record

CDH11 inhibits proliferation and invasion in head and neck cancer
dc.contributor.authorPiao, Songlin
dc.contributor.authorInglehart, Ronald C.
dc.contributor.authorScanlon, Christina Springstead
dc.contributor.authorRusso, Nickole
dc.contributor.authorBanerjee, Rajat
dc.contributor.authorD’Silva, Nisha J.
dc.date.accessioned2017-02-02T22:00:38Z
dc.date.available2018-04-02T18:03:23Zen
dc.date.issued2017-02
dc.identifier.citationPiao, Songlin; Inglehart, Ronald C.; Scanlon, Christina Springstead; Russo, Nickole; Banerjee, Rajat; D’Silva, Nisha J. (2017). "CDH11 inhibits proliferation and invasion in head and neck cancer." Journal of Oral Pathology & Medicine 46(2): 89-97.
dc.identifier.issn0904-2512
dc.identifier.issn1600-0714
dc.identifier.urihttps://hdl.handle.net/2027.42/135974
dc.publisherWiley Periodicals, Inc.
dc.subject.othermeta‐analysis
dc.subject.otherCDH11
dc.subject.othersquamous cell carcinoma
dc.titleCDH11 inhibits proliferation and invasion in head and neck cancer
dc.typeArticleen_US
dc.rights.robotsIndexNoFollow
dc.subject.hlbsecondlevelDentistry
dc.subject.hlbtoplevelHealth Sciences
dc.description.peerreviewedPeer Reviewed
dc.description.bitstreamurlhttp://deepblue.lib.umich.edu/bitstream/2027.42/135974/1/jop12471_am.pdf
dc.description.bitstreamurlhttp://deepblue.lib.umich.edu/bitstream/2027.42/135974/2/jop12471.pdf
dc.identifier.doi10.1111/jop.12471
dc.identifier.sourceJournal of Oral Pathology & Medicine
dc.identifier.citedreferenceYap AS, Gomez GA, Parton RG. Adherens junctions revisualized: organizing cadherins as nanoassemblies. Dev Cell 2015; 35: 12 – 20.
dc.identifier.citedreferenceEstilo CL, Oc P, Talbot S, et al. Oral tongue cancer gene expression profiling: identification of novel potential prognosticators by oligonucleotide microarray analysis. BMC Cancer 2009; 9: 11.
dc.identifier.citedreferenceGinos MA, Page GP, Michalowicz BS, et al. Identification of a gene expression signature associated with recurrent disease in squamous cell carcinoma of the head and neck. Cancer Res 2004; 64: 55 – 63.
dc.identifier.citedreferenceKuriakose MA, Chen WT, He ZM, et al. Selection and validation of differentially expressed genes in head and neck cancer. Cell Mol Life Sci 2004; 61: 1372 – 83.
dc.identifier.citedreferencePeng CH, Liao CT, Peng SC, et al. A novel molecular signature identified by systems genetics approach predicts prognosis in oral squamous cell carcinoma. PLoS One 2011; 6: e23452.
dc.identifier.citedreferencePyeon D, Newton MA, Lambert PF, et al. Fundamental differences in cell cycle deregulation in human papillomavirus‐positive and human papillomavirus‐negative head/neck and cervical cancers. Cancer Res 2007; 67: 4605 – 19.
dc.identifier.citedreferenceSchlingemann J, Habtemichael N, Ittrich C, et al. Patient‐based cross‐platform comparison of oligonucleotide microarray expression profiles. Lab Invest 2005; 85: 1024 – 39.
dc.identifier.citedreferenceTalbot SG, Estilo C, Maghami E, et al. Gene expression profiling allows distinction between primary and metastatic squamous cell carcinomas in the lung. Cancer Res 2005; 65: 3063 – 71.
dc.identifier.citedreferenceToruner GA, Ulger C, Alkan M, et al. Association between gene expression profile and tumor invasion in oral squamous cell carcinoma. Cancer Genet Cytogenet 2004; 154: 27 – 35.
dc.identifier.citedreferenceYe H, Yu T, Temam S, et al. Transcriptomic dissection of tongue squamous cell carcinoma. BMC Genom 2008; 9: 69.
dc.identifier.citedreferenceBanerjee R, Russo N, Liu M, et al. TRIP13 promotes error‐prone nonhomologous end joining and induces chemoresistance in head and neck cancer. Nat Commun 2014; 5: 4527.
dc.identifier.citedreferenceTorres S, Bartolome RA, Mendes M, et al. Proteome profiling of cancer‐associated fibroblasts identifies novel proinflammatory signatures and prognostic markers for colorectal cancer. Clin Cancer Res 2013; 19: 6006 – 19.
dc.identifier.citedreferenceChu K, Cheng CJ, Ye X, et al. Cadherin‐11 promotes the metastasis of prostate cancer cells to bone. Mol Cancer Res 2008; 6: 1259 – 67.
dc.identifier.citedreferenceMarie PJ, Hay E, Modrowski D, et al. Cadherin‐mediated cell‐cell adhesion and signaling in the skeleton. Calcif Tissue Int 2014; 94: 46 – 54.
dc.identifier.citedreferenceAlimperti S, Andreadis ST. CDH2 and CDH11 act as regulators of stem cell fate decisions. Stem Cell Res 2015; 14: 270 – 82.
dc.identifier.citedreferenceBujko M, Kober P, Mikula M, et al. Expression changes of cell‐cell adhesion‐related genes in colorectal tumors. Oncol Lett 2015; 9: 2463 – 70.
dc.identifier.citedreferenceChoi P, Jordan CD, Mendez E, et al. Examination of oral cancer biomarkers by tissue microarray analysis. Arch Otolaryngol Head Neck Surg 2008; 134: 539 – 46.
dc.identifier.citedreferenceMueller DW, Bosserhoff AK. MicroRNA miR‐196a controls melanoma‐associated genes by regulating HOX‐C8 expression. Int J Cancer 2011; 129: 1064 – 74.
dc.identifier.citedreferenceSandgren J, Andersson R, Rada‐Iglesias A, et al. Integrative epigenomic and genomic analysis of malignant pheochromocytoma. Exp Mol Med 2010; 42: 484 – 502.
dc.identifier.citedreferenceNakajima G, Patino‐Garcia A, Bruheim S, et al. CDH11 expression is associated with survival in patients with osteosarcoma. Cancer Genomics Proteomics 2008; 5: 37 – 42.
dc.identifier.citedreferencede Craene B, Berx G. Regulatory networks defining EMT during cancer initiation and progression. Nat Rev Cancer 2013; 13: 97 – 110.
dc.identifier.citedreferenceGoto M, Mitra RS, Liu M, et al. Rap1 stabilizes beta‐catenin and enhances beta‐catenin‐dependent transcription and invasion in squamous cell carcinoma of the head and neck. Clin Cancer Res 2010; 16: 65 – 76.
dc.identifier.citedreferenceCirillo N. Merging experimental data and in silico analysis: a systems‐level approach to autoimmune disease and cancer. Expert Rev Clin Immunol 2012; 8: 361 – 72.
dc.identifier.citedreferenceRhodes DR, Kalyana‐Sundaram S, Mahavisno V, et al. Mining for regulatory programs in the cancer transcriptome. Nat Genet 2005; 37: 579 – 83.
dc.identifier.citedreferenceYagi T, Takeichi M. Cadherin superfamily genes: functions, genomic organization, and neurologic diversity. Genes Dev 2000; 14: 1169 – 80.
dc.identifier.citedreferencePishvaian MJ, Feltes CM, Thompson P, et al. Cadherin‐11 is expressed in invasive breast cancer cell lines. Cancer Res 1999; 59: 947 – 52.
dc.identifier.citedreferenceHuang CF, Lira C, Chu K, et al. Cadherin‐11 increases migration and invasion of prostate cancer cells and enhances their interaction with osteoblasts. Cancer Res 2010; 70: 4580 – 9.
dc.identifier.citedreferenceMarchong MN, Yurkowski C, Ma C, et al. Cdh11 acts as a tumor suppressor in a murine retinoblastoma model by facilitating tumor cell death. PLoS Genet 2010; 6: e1000923.
dc.identifier.citedreferenceLi L, Ying J, Li H, et al. The human cadherin 11 is a pro‐apoptotic tumor suppressor modulating cell stemness through Wnt/beta‐catenin signaling and silenced in common carcinomas. Oncogene 2012; 31: 3901 – 12.
dc.identifier.citedreferenceCromer A, Carles A, Millon R, et al. Identification of genes associated with tumorigenesis and metastatic potential of hypopharyngeal cancer by microarray analysis. Oncogene 2004; 23: 2484 – 98.
dc.owningcollnameInterdisciplinary and Peer-Reviewed


Files in this item

Name:
jop12471_am.pdf
Size:
387.3KB
Format:
PDF
View/Open
Name:
jop12471.pdf
Size:
587.2KB
Format:
PDF
View/Open

Show simple item record

Remediation of Harmful Language

The University of Michigan Library aims to describe library materials in a way that respects the people and communities who create, use, and are represented in our collections. Report harmful or offensive language in catalog records, finding aids, or elsewhere in our collections anonymously through our metadata feedback form. More information at Remediation of Harmful Language.

Accessibility

If you are unable to use this file in its current format, please select the Contact Us link and we can modify it to make it more accessible to you.